Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients.

MLA

Mufti, Kheireddin, et al. “Genomic Variations Associated with Risk and Protection against Vincristine-Induced Peripheral Neuropathy in Pediatric Cancer Patients.” NPJ Genomic Medicine, vol. 9, no. 1, Nov. 2024, p. 56. EBSCOhost, https://doi.org/10.1038/s41525-024-00443-7.

APA

Mufti, K., Cordova, M., Scott, E. N., Trueman, J. N., Lovnicki, J. M., Loucks, C. M., Rassekh, S. R., Ross, C. J. D., & Carleton, B. C. (2024). Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients. NPJ Genomic Medicine, 9(1), 56. https://doi.org/10.1038/s41525-024-00443-7

Chicago

Mufti, Kheireddin, Miguel Cordova, Erika N Scott, Jessica N Trueman, Jessica M Lovnicki, Catrina M Loucks, Shahrad R Rassekh, Colin J D Ross, and Bruce C Carleton. 2024. “Genomic Variations Associated with Risk and Protection against Vincristine-Induced Peripheral Neuropathy in Pediatric Cancer Patients.” NPJ Genomic Medicine 9 (1): 56. doi:10.1038/s41525-024-00443-7.